Entera Bio Insider Trades
NASDAQ: ENTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 8 · $140.88K
- Sales
- 0 · $0
- Shares bought / sold
- 101.50K / 0
- Net activity
- Net buying $140,882
Entera Bio insider activity
Over the last 12 months, Entera Bio insiders reported 23 transactions on SEC Form 4: 8 open-market purchases and 0 sales. Insiders bought $140,882 and sold $0 worth of stock, for net insider buying of $140,882. The most recent filing shows Rubin Steven D (Director) reporting a transaction in 19,117 shares on Aug 7, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ENTX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ENTX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 7, 2026 | Germano Geno JDirector | Award | 25,014 | — | Form 4 |
| Aug 7, 2026 | Ellis SeanDirector | Award | 20,034 | — | Form 4 |
| Aug 7, 2026 | Taitel HayaDirector | Award | 20,790 | — | Form 4 |
| Aug 7, 2026 | Malca YonatanDirector | Award | 22,815 | — | Form 4 |
| Aug 7, 2026 | Rubin Steven DDirector | Award | 19,117 | — | Form 4 |
| Jul 14, 2026 | Toledano Miranda JayneChief Executive Officer | Award | 72,993 | — | Form 4 |
| Jul 14, 2026 | Toledano Miranda JayneChief Executive Officer | Award | 347,567 | — | Form 4 |
| May 7, 2026 | Burshtein GregoryChief of R&D | Award | 87,591 | — | Form 4 |
| May 7, 2026 | Yaacov-Garbeli DanaChief Financial Officer | Award | 58,394 | — | Form 4 |
| May 7, 2026 | Galitzer HillelChief Operating Officer | Award | 72,993 | — | Form 4 |
| Mar 9, 2026 | Germano Geno JDirector | Buy | 20,000 | $26.00K | Form 4 |
| Mar 5, 2026 | Ellis SeanDirector | Buy | 10,000 | $12.30K | Form 4 |
| Feb 12, 2026 | Rubin Steven DDirector | Buy | 5,000 | $7.45K | Form 4 |
| Feb 10, 2026 | Germano Geno JDirector | Buy | 20,000 | $29.80K | Form 4 |
| Feb 10, 2026 | Taitel HayaDirector | Buy | 7,500 | $11.10K | Form 4 |
| Feb 9, 2026 | Rubin Steven DDirector | Buy | 10,000 | $12.00K | Form 4 |
| Feb 9, 2026 | Ellis SeanDirector | Buy | 18,000 | $22.32K | Form 4 |
| Jan 1, 2026 | Malca YonatanDirector | Award | 30,157 | — | Form 4 |
| Jan 1, 2026 | Ellis SeanDirector | Award | 25,371 | — | Form 4 |
| Jan 1, 2026 | OSTROV GERALD MDirector | Award | 28,721 | — | Form 4 |
| Jan 1, 2026 | Taitel HayaDirector | Award | 26,329 | — | Form 4 |
| Jan 1, 2026 | LIEBERMAN GERALD MDirector | Award | 38,294 | — | Form 4 |
| Dec 29, 2025 | Toledano Miranda JayneChief Executive Officer | Buy | 11,000 | $19.91K | Form 4 |
| Jul 16, 2025 | Burshtein GregoryChief of R&D | Award | 26,316 | — | Form 4 |
| Jul 16, 2025 | Yaacov-Garbeli DanaChief Financial Officer | Award | 26,316 | — | Form 4 |
| Jul 16, 2025 | Toledano Miranda JayneChief Executive Officer | Award | 43,860 | — | Form 4 |
| Jul 16, 2025 | Toledano Miranda JayneChief Executive Officer | Award | 136,842 | — | Form 4 |
| Apr 28, 2025 | Galitzer HillelChief Operating Officer | Award | 26,316 | — | Form 4 |
| Apr 1, 2025 | LIEBERMAN GERALD MDirector | Option exercise | 23,952 | $23.95K | Form 4 |
| Jan 15, 2025 | LIEBERMAN GERALD MDirector | Award | 10,717 | — | Form 4 |
| Jan 15, 2025 | Taitel HayaDirector | Award | 6,922 | — | Form 4 |
| Jan 15, 2025 | Ellis SeanDirector | Award | 7,100 | — | Form 4 |
| Jan 15, 2025 | Malca YonatanDirector | Award | 8,216 | — | Form 4 |
| Jan 15, 2025 | OSTROV GERALD MDirector | Award | 8,038 | — | Form 4 |
| Oct 2, 2024 | Malca YonatanDirector | Award | 8,639 | — | Form 4 |
| Oct 2, 2024 | LIEBERMAN GERALD MDirector | Award | 11,269 | — | Form 4 |
| Oct 2, 2024 | OSTROV GERALD MDirector | Award | 8,452 | — | Form 4 |
| Oct 2, 2024 | Taitel HayaDirector | Award | 7,278 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4